Abstract:The highly regulated processes of mitochondrial fusion (joining), fission (division) and trafficking, collectively called mitochondrial dynamics, determine cell-type specific morphology, intracellular distribution and activity of these critical organelles. Mitochondria are critical for cardiac function, while their structural and functional abnormalities contribute to several common cardiovascular diseases, including heart failure (HF). The tightly balanced mitochondrial fusion and fission determine number, morphology and activity of these multifunctional organelles. Although the intracellular architecture of mature cardiomyocytes greatly restricts mitochondrial dynamics, this process occurs in the adult human heart. Fusion and fission modulate multiple mitochondrial functions, ranging from energy and reactive oxygen species production to Ca2+ homeostasis and cell death, allowing the heart to respond properly to body demands. Tightly controlled balance between fusion and fission is of utmost importance in the high energy-demanding cardiomyocytes. A shift toward fission leads to mitochondrial fragmentation, while a shift toward fusion results in the formation of enlarged mitochondria and in the fusion of damaged mitochondria with healthy organelles. Mfn1, Mfn2 and OPA1 constitute the core machinery promoting mitochondrial fusion, whereas Drp1, Fis1, Mff and MiD49/51 are the core components of fission machinery. Growing evidence suggests that fusion/fission factors in adult cardiomyocytes play essential noncanonical roles in cardiac development, Ca2+ signaling, mitochondrial quality control and cell death. Impairment of this complex circuit causes cardiomyocyte dysfunction and death contributing to heart injury culminating in HF. Pharmacological targeting of components of this intricate network may be a novel therapeutic modality for HF treatment.

Mitochondrial ion channels as targets for cardioprotection

Mitochondria-associated membrane-modulated Ca<SUP>2+</SUP> transfer: A potential treatment target in cardiac ischemia reperfusion injury and heart failure

Mitochondria: a target for myocardial protection

Mitochondrial Fusion and Fission in Neuronal Death Induced by Cerebral Ischemia-Reperfusion and Its Clinical Application: A Mini-Review

The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury

Mitochondrial quality surveillance as a therapeutic target in myocardial infarction

Myocardial Ischemia-Reperfusion Injury: Therapeutics from a Mitochondria-Centric Perspective

Role of mitochondrial quality surveillance in myocardial infarction: From bench to bedside

Mitochondrial Kinase Signaling for Cardioprotection

Myocardial ischemia-reperfusion injury: a neglected therapeutic target

Mitochondrial dynamics and cell death in heart failure

Research progress of mitochondrial ATP-sensitive potassium channels in myocardial protection

Dynamic Changes in Ion Channels during Myocardial Infarction and Therapeutic Challenges

Mitochondrial calcium in cardiac ischemia/reperfusion injury and cardioprotection

Mitophagy and Mitochondrial Integrity in Cardiac Ischemia-Reperfusion Injury

The role of mitochondrial membrane potential in ischemic heart failure

Alternative Targets for Modulators of Mitochondrial Potassium Channels

Mitophagy As a Mitochondrial Quality Control Mechanism in Myocardial Ischemic Stress: from Bench to Bedside

Neutrophil-mediated cardiac damage after acute myocardial infarction: Significance of defining a new target cell-type for developing cardioprotective drugs.

Effective Agents Targeting the Mitochondria and Apoptosis to Protect the Heart

Novel Insights into the Role of Mitochondrial Fusion and Fission in Cardiomyocyte Apoptosis Induced by Ischemia/reperfusion.